[1] |
Tan SS, Gao G, Koch S. Big data and analytics in healthcare[J]. Methods Inf Med, 2015,54(6):546⁃547. doi: 10.3414/ME15⁃06⁃1001.
|
[2] |
Stajic J, Stone R, Chin G, et al. Artificial intelligence. Rise of the machines[J]. Science, 2015,349(6245):248⁃249. doi: 10.1126/science.349.6245.248.
|
[3] |
Jordan MI, Mitchell TM. Machine learning: trends, perspectives, and prospects[J]. Science, 2015,349(6245):255⁃260. doi: 10.1126/ science.aaa8415.
|
[4] |
LeCun Y, Bengio Y, Hinton G. Deep learning[J]. Nature, 2015,521(7553):436⁃444. doi: 10.1038/nature14539.
|
[5] |
Wang S, Summers RM. Machine learning and radiology[J]. Med Image Anal, 2012,16(5):933⁃951. doi: 10.1016/j.media.2012.02. 005.
|
[6] |
Gulshan V, Peng L, Coram M, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs[J]. JAMA, 2016,316(22):2402⁃2410. doi: 10.1001/jama.2016.17216.
|
[7] |
Kooi T, Litjens G, van Ginneken B, et al. Large scale deep learning for computer aided detection of mammographic lesions[J]. Med Image Anal, 2017,35:303⁃312. doi: 10.1016/j.media. 2016.7.007.
|
[8] |
Herweh C, Ringleb PA, Rauch G, et al. Performance of e⁃ASPECTS software in comparison to that of stroke physicians on assessing CT scans of acute ischemic stroke patients[J]. Int J Stroke, 2016,11(4):438⁃445. doi: 10.1177/1747493016632244.
|
[9] |
Holder LB, Haque MM, Skinner MK. Machine learning for epigenetics and future medical applications[J]. Epigenetics, 2017,12(7):505⁃514. doi: 10.1080/15592294.2017.1329068.
|
[10] |
Bakkar N, Kovalik T, Lorenzini I, et al. Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA⁃binding proteins altered in amyotrophic lateral sclerosis[J]. Acta Neuropathol, 2018,135(2):227⁃247. doi: 10.1007/s00401⁃017⁃1785⁃8.
|
[11] |
Kim SY, Diggans J, Pankratz D, et al. Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high⁃dimensional transcriptional data[J]. Lancet Respir Med, 2015,3(6):473⁃482. doi: 10.1016/S2213⁃2600(15)00140⁃X.
|
[12] |
Dorman SN, Baranova K, Knoll JH, et al. Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning[J]. Mol Oncol, 2016,10(1):85⁃100. doi: 10. 1016/j.molonc.2015.07.006.
|
[13] |
Chamberlain DB, Kodgule R, Fletcher RR. A mobile platform for automated screening of asthma and chronic obstructive pulmonary disease[J]. Conf Proc IEEE Eng Med Biol Soc, 2016,2016:5192⁃5195. doi: 10.1109/EMBC.2016.7591897.
|
[14] |
Kermany DS, Goldbaum M, Cai W, et al. Identifying medical diagnoses and treatable diseases by image⁃based deep learning[J]. Cell, 2018,172(5):1122⁃1131. doi: 10.1016/j.cell.2018.02. 010.
|
[15] |
Zhang H, Qiu X, Zou Y, et al. A dye⁃assisted paper⁃based point⁃of⁃care assay for fast and reliable blood grouping[J]. Sci Transl Med, 2017,9(381). pii: eaaf9209. doi: 10.1126/scitranslmed.aaf 9209.
|
[16] |
Weng SF, Reps J, Kai J, et al. Can machine⁃learning improve cardiovascular risk prediction using routine clinical data?[J]. PLoS One, 2017,12(4):e0174944. doi: 10.1371/journal.pone.0174 944.
|
[17] |
Menden MP, Iorio F, Garnett M, et al. Machine learning pre⁃diction of cancer cell sensitivity to drugs based on genomic and chemical properties[J]. PLoS One, 2013,8(4):e61318. doi: 10. 1371/journal.pone.0061318.
|
[18] |
Choi H, Jin KH. Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging[J]. Behav Brain Res, 2018,344:103⁃109. doi: 10.1016/j.bbr.2018.02.017.
|
[19] |
Hazlett HC, Gu H, Munsell BC, et al. Early brain development in infants at high risk for autism spectrum disorder[J]. Nature, 2017,542(7641):348⁃351. doi: 10.1038/nature21369.
|
[20] |
Marchetti MA, NCF C, Dusza SW, et al. Results of the 2016 international skin imaging collaboration international symposium on biomedical imaging challenge: comparison of the accuracy of computer algorithms to dermatologists for the diagnosis of melanoma from dermoscopic images[J]. J Am Acad Dermatol, 2018,78(2):270⁃277. doi: 10.1016/j.jaad.2017.08.016.
|
[21] |
Masood A, Al⁃Jumaily A. Semi⁃advised learning model for skin cancer diagnosis based on histopathalogical images[J]. Conf Proc IEEE Eng Med Biol Soc, 2016,2016:631⁃634. doi: 10.1109/EMBC. 2016.7590781.
|
[22] |
Esteva A, Kuprel B, Novoa RA, et al. Dermatologist⁃level classification of skin cancer with deep neural networks[J]. Nature, 2017,542(7639):115⁃118. doi: 10.1038/nature21056.
|
[23] |
Thissen M, Udrea A, Hacking M, et al. mHealth App for risk assessment of pigmented and nonpigmented skin lesions⁃a study on sensitivity and specificity in detecting malignancy[J]. Telemed J E Health, 2017,23(12):948⁃954. doi: 10.1089/tmj. 2016.0259.
|
[24] |
Arevalo J, Cruz⁃Roa A, Arias V, et al. An unsupervised feature learning framework for basal cell carcinoma image analysis[J]. Artif Intell Med, 2015,64(2):131⁃145. doi: 10.1016/j.artmed.2015. 04.004.
|
[25] |
Zhang G, Yin J, Su X, et al. Augmenting multi⁃instance multilabel learning with sparse bayesian models for skin biopsy image analysis[J]. Biomed Res Int, 2014,2014:305629. doi: 10.1155/2014/305629.
|
[26] |
Shrivastava VK, Londhe ND, Sonawane RS, et al. A novel and robust Bayesian approach for segmentation of psoriasis lesions and its risk stratification[J]. Comput Methods Programs Biomed, 2017,150:9⁃22. doi: 10.1016/j.cmpb.2017.07.011.
|
[27] |
Han SS, Park GH, Lim W, et al. Deep neural networks show an equivalent and often superior performance to dermatologists in onychomycosis diagnosis: Automatic construction of onychomy⁃cosis datasets by region⁃based convolutional deep neural network[J]. PLoS One, 2018,13(1):e0191493. doi: 10.1371/journal.pone. 0191493.
|
[28] |
Min S, Kong HJ, Yoon C, et al. Development and evaluation of an automatic acne lesion detection program using digital image processing[J]. Skin Res Technol, 2013,19(1):e423⁃e432. doi: 10. 1111/j.1600⁃0846.2012.00660.x.
|
[29] |
Roffman D, Hart G, Girardi M, et al. Predicting non⁃melanoma skin cancer via a multi⁃parameterized artificial neural network[J]. Sci Rep, 2018,8(1):1701. doi: 10.1038/s41598⁃018⁃19907⁃9.
|
[30] |
Strickland J, Zang Q, Paris M, et al. Multivariate models for prediction of human skin sensitization hazard[J]. J Appl Toxicol, 2017,37(3):347⁃360. doi: 10.1002/jat.3366.
|
[31] |
Zeller KS, Forreryd A, Lindberg T, et al. The GARD platform for potency assessment of skin sensitizing chemicals[J]. ALTEX, 2017,34(4):539⁃559. doi: 10.14573/altex.1701101.
|
[32] |
Moss GP, Shah AJ, Adams RG, et al. The application of discriminant analysis and Machine Learning methods as tools to identify and classify compounds with potential as transdermal enhancers[J]. Eur J Pharm Sci, 2012,45(1⁃2):116⁃127. doi: 10. 1016/j.ejps.2011.10.027.
|
[33] |
Baba H, Takahara J, Yamashita F, et al. Modeling and prediction of solvent effect on human skin permeability using support vector regression and random forest[J]. Pharm Res, 2015,32(11):3604⁃3617. doi: 10.1007/s11095⁃015⁃1720⁃4.
|
[34] |
Dong X, Han Y, Sun Z, et al. Actin gamma 1, a new skin cancer pathogenic gene, identified by the biological feature⁃based classifi⁃cation[J]. J Cell Biochem, 2018,119(2):1406⁃1419. doi: 10.1002/ jcb.26301.
|